{"filing":{"accession_number":"0001493152-26-038391","cik":"0001505497","ticker":"BRTX","company_name":"BioRestorative Therapies, Inc.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-07","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/form8-k.htm"},"events":[{"id":27924,"run_id":25501,"accession_number":"0001493152-26-038391","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"BioRestorative Therapies suspended all orders and shipments of its biocosmeceutical product lines (ExoCR and BioX products) effective immediately, pending business review and regulatory assessment. This is a material operational event—a suspension of product sales affecting revenue-generating business lines—that does not fit the specific categories of workforce_reduction, material_litigation, or other named types. The company has not decided to discontinue the lines, but the immediate suspension pending regulatory review represents a significant operational disruption material to investors.","company_name":"BioRestorative Therapies, Inc.","ticker":"BRTX","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":29649,"accession_number":"0001493152-26-038391","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioRestorative Therapies suspended all orders and shipments of its biocosmeceutical product lines (ExoCR and BioX products) effective immediately, pending business review and regulatory assessment. This is a material operational event—a suspension of product sales affecting revenue-generating business lines—that does not fit the specific categories of workforce_reduction, material_litigation, or other named types. The company has not decided to discontinue the lines, but the immediate suspension pending regulatory review represents a significant operational disruption material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T20:26:19.931980+00:00","company_name":"BioRestorative Therapies, Inc.","ticker":"BRTX","filing_date":"2026-08-14"}]}